MEMRX | VEMAX | MEMRX / VEMAX | |
Total Expense Ratio | 2.06 | 0.13 | 1,585% |
Annual Report Gross Expense Ratio | 2.11 | 0.13 | 1,623% |
Fund Existence | 17 years | 19 years | - |
Gain YTD | 16.968 | 12.067 | 141% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.95B | 124B | 7% |
Annual Yield % from dividends | 2.03 | 2.76 | 74% |
Returns for 1 year | 15.83 | 11.27 | 140% |
Returns for 3 years | 43.04 | 31.73 | 136% |
Returns for 5 years | 24.86 | 25.99 | 96% |
Returns for 10 years | 48.55 | 46.07 | 105% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PPLT | 128.20 | 4.12 | +3.32% |
abrdn Physical Platinum Shares ETF | |||
PEX | 28.79 | 0.16 | +0.56% |
ProShares Global Listed Private Equity | |||
BNDI | 46.79 | -0.23 | -0.50% |
NEOS Enhanced Income Aggregate Bond ETF | |||
AGIX | 30.92 | -0.46 | -1.47% |
KraneShares Artfcl Intllgnc and Tech ETF | |||
BBH | 158.22 | -2.92 | -1.81% |
VanEck Biotech ETF |